-
Meropenem: Mechanism and Infection Research
2026-08-26
Meropenem is a β-lactam antibiotic carbapenem that inhibits bacterial cell-wall synthesis through penicillin-binding proteins. Its broad in vitro activity supports Gram-negative bacterial infection models, while recent carbapenem-resistance data show why susceptibility and resistance-gene testing must accompany experimental use.
-
Nanozyme Liposomes for Facial Nerve Repair
2026-08-26
A 2026 Materials Today Bio study developed NP41-modified, ROS-responsive liposomes that co-deliver Ferrostatin-1 and Mn-doped CeO2 nanozymes to suppress oxidative injury and ferroptosis after facial nerve damage. In mice, this strategy improved the inflammatory microenvironment, Schwann cell preservation, remyelination, and functional recovery, while providing a useful framework for tissue-targeted ferroptosis modulation.
-
SmD2 Acetylation and PARP Inhibitor Sensitivity in HCC
2026-08-25
This Nature Communications study identifies the spliceosome core protein SmD2 as an acetylation-regulated determinant of BRCA1/FANC cassette-exon usage, DNA-repair capacity, and PARP inhibitor response in hepatocellular carcinoma. Its preclinical data support a mechanistic rationale for combining HDAC-axis intervention with PARP inhibition, while highlighting the need for HCC-specific validation and biomarker development.
-
Phenytoin B2271 for Reproducible Assays
2026-08-25
This scenario-based guide explains how Phenytoin, SKU B2271, can be introduced into sodium-channel, electrophysiology, and exploratory cell-based workflows without confusing solvent effects or enzyme data with direct cytotoxicity. It covers preparation, assay controls, interpretation, and practical vendor-selection criteria.
-
DFO: Latent Fingerprint Detection Workflow
2026-08-24
DFO (9H-1,8-Diazafluoren-9-one) converts amino-acid residues in latent prints into a fluorescence-based detection signal, making it especially useful for paper and other porous evidence. This practical guide covers solvent selection, controlled development, imaging, optimization, and an important distinction between forensic DFO and deferoxamine mesylate.
-
ATP Solution (100 mM) for mRNA Assays
2026-08-24
ATP Solution supports reproducible transcription, kinase, ligation, and phosphorylation workflows. This article connects ATP quality and handling decisions to the assay architecture behind localized p21 mRNA–LNP research, offering a practical framework beyond conventional product overviews.
-
Measuring Cancer Drug Response Beyond Relative Viability
2026-08-23
Hannah R. Schwartz’s 2022 dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer response. Its central finding is that drug-induced growth inhibition and cell death often occur together but differ in magnitude and timing, supporting paired, time-aware assay design.
-
1-methyl Adenosine: From Signal to Biology
2026-08-22
1-methyl Adenosine is more than a modified nucleoside measurement target: it can connect RNA turnover, metabolic state, and disease-associated biomarker signals. This article explains how isomer-resolved UHPLC–MS/MS and careful sample handling improve interpretation in RNA modification research and cancer metabolism studies.
-
hiPSC Intestinal Organoids for Pharmacokinetic Studies
2026-08-22
Saito and colleagues developed a direct three-dimensional cluster-culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The organoids could be propagated, cryopreserved, and converted into epithelial monolayers containing enterocytes with cytochrome P450 and transporter activities, offering a practical human model for oral drug pharmacokinetic research.
-
GW4064: Practical FXR Activation Workflows
2026-08-21
GW4064 is a selective non-steroidal FXR agonist for connecting receptor activation with bile acid transport, lipid regulation, and hepatic injury phenotypes. This practical guide covers assay setup, transporter-focused workflows, controls, and troubleshooting for reproducible metabolic research.
-
Anagliptin Vasorelaxation via Kv Channels and SERCA
2026-08-20
A 2025 Acta Diabetologica study shows that Anagliptin relaxes phenylephrine-contracted rabbit aortic rings through a pharmacological pathway involving voltage-dependent K+ channels and the SERCA pump. The response was independent of endothelium, cAMP/PKA signaling, cGMP/PKG signaling, and several other vascular K+ channel classes, providing a focused framework for vasorelaxant mechanism research.
-
Abiraterone acetate in 3D Prostate Cancer Models
2026-08-20
Use Abiraterone acetate as a mechanistic CYP17 inhibitor in patient-derived prostate spheroids, where tissue architecture, steroid gradients, and androgen receptor signaling can be evaluated together. This workflow combines formulation control, orthogonal readouts, and reference-study benchmarks to distinguish true pathway effects from poor compound exposure or model variability.
-
Recombinant Human IL-15: Assays and Workflows
2026-08-19
Recombinant Human IL-15 enables controlled T-cell activation, Natural killer cell proliferation, and immune response modulation in defined research workflows. This guide combines assay design, reconstitution, optimization, and troubleshooting with a cautious neuroimmune bridge inspired by recent innate-defense research.
-
Cholesterol as a Control in mRNA-LNP Studies
2026-08-19
Cholesterol is more than a membrane ingredient: it is an important experimental variable when interpreting lipid nanoparticle delivery and bladder cancer assays. This guide connects cholesterol handling, assay design, and the localized p21 mRNA-LNP findings without overstating cholesterol-specific causality.
-
Modified TPO mRNA Stimulates Thrombopoiesis in Mice
2026-08-18
This study developed chemically modified, in-vitro-transcribed thrombopoietin mRNA and delivered it with lipid nanoparticles to produce a transient platelet-generating signal in mice. The results show dose-dependent TPO expression, increased reticulated and total platelets, and rapid recovery in an antibody-induced thrombocytopenia model, while also clarifying which RNA-production and delivery steps are essential for translation.